TKO Group Holdings Inc vs Veeva Systems — how do they compare? TKO Group Holdings Inc trades at $191.08 (market cap $14.28B), while Veeva Systems trades at $260.88 (market cap $42.88B). The key difference: Veeva Systems is far larger — about 3× TKO Group Holdings Inc's market cap, and TKO Group Holdings Inc pays a 1.62% dividend while Veeva Systems pays none. Which is the better fit depends on your goals.
| TKO | VEEV | |
|---|---|---|
Market Cap | $14.28B | $42.88B |
Sector | Technology | Technology |
52-Week High | $224.96 | $306.22 |
52-Week Low | $176.49 | $151.43 |
Enterprise Value | $18.64B | $35.79B |
Dividend Yield | 1.62% | — |
Signals from Pluang's Aura AI — not financial advice
TKO trades at $195.32, up 5.01% today, with a bullish technical outlook and strong analyst support. Recent Q2 2026 earnings showed revenue growth to $1.5 billion, though EPS missed expectations. The company benefits from media rights strength in UFC and WWE, with revenue projected to rise to $5.3 billion in 2026. Positive sentiment is driven by dividend declarations and conference participation.
The outlook is positive with a consensus price target of $228.17, implying 17% upside. Risks include earnings volatility and competitive pressures in sports entertainment. Institutional ownership trends and bullish analyst ratings (89% buy) support a favorable investment case, but investors should monitor execution on guidance.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →